{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T06:55:22Z","timestamp":1776754522785,"version":"3.51.2"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Pain Headache Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11916-026-01475-7","type":"journal-article","created":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T06:34:19Z","timestamp":1776753259000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Neuroscientific Basis of Ketamine as an Analgesic and Emerging Role in the Management of Depression"],"prefix":"10.1007","volume":"30","author":[{"given":"Navy C.","family":"Coggins","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanson A.","family":"Chokr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tricia A.","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mihir","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sahar","family":"Shekoohi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan D.","family":"Kaye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,21]]},"reference":[{"issue":"3","key":"1475_CR1","doi-asserted-by":"publisher","first-page":"283","DOI":"10.4103\/0259-1162.143110","volume":"8","author":"M Kurdi","year":"2014","unstructured":"Kurdi M, Theerth K, Deva R. Ketamine: current applications in anesthesia, pain, and critical care. Anesth Essays Res. 2014;8(3):283. https:\/\/doi.org\/10.4103\/0259-1162.143110.","journal-title":"Anesth Essays Res"},{"issue":"1","key":"1475_CR2","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s40263-025-01234-z","volume":"40","author":"G Pickering","year":"2026","unstructured":"Pickering G, Morel V, Voute M. Managing chronic pain: the ketamine option. CNS Drugs. 2026;40(1):19\u201341. https:\/\/doi.org\/10.1007\/s40263-025-01234-z.","journal-title":"CNS Drugs"},{"issue":"1","key":"1475_CR3","doi-asserted-by":"publisher","DOI":"10.1017\/S1092852925100333","volume":"30","author":"JM Quintero","year":"2025","unstructured":"Quintero JM, Bustos RH, Lechtig-Wassermann S, Beltran S, Zarate CA. Ketamine in clinical practice: transitioning from anesthetic agent to psychiatric therapeutic. CNS Spectr. 2025;30(1):e51. https:\/\/doi.org\/10.1017\/S1092852925100333.","journal-title":"CNS Spectr"},{"key":"1475_CR4","unstructured":"Rosenbaum SB, Gupta V, Patel P, Palacios JL. Ketamine. In: StatPearls. StatPearls Publishing; 2025. Accessed February 24, 2026. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK470357\/"},{"key":"1475_CR5","unstructured":"HKG LPD Ketamine HCl - Ketalar. Accessed February 25. 2026. https:\/\/labeling.pfizer.com\/ShowLabeling.aspx?id=14017"},{"key":"1475_CR6","unstructured":"UpToDate L. Trusted drug decision support for health professionals. Accessed February 25, 2026. https:\/\/www.wolterskluwer.com\/en\/solutions\/uptodate\/pro\/lexidrug"},{"issue":"6","key":"1475_CR7","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1111\/cns.12099","volume":"19","author":"G Mion","year":"2013","unstructured":"Mion G, Villevieille T. Ketamine pharmacology: an update ( Pharmacodynamics and Molecular Aspects, Recent Findings ). CNS Neurosci Ther. 2013;19(6):370\u201380. https:\/\/doi.org\/10.1111\/cns.12099.","journal-title":"CNS Neurosci Ther"},{"issue":"9","key":"1475_CR8","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1097\/EJA.0000000000000638","volume":"34","author":"G Mion","year":"2017","unstructured":"Mion G. History of anaesthesia: the ketamine story \u2013 past, present and future. Eur J Anaesthesiol. 2017;34(9):571\u20135. https:\/\/doi.org\/10.1097\/EJA.0000000000000638.","journal-title":"Eur J Anaesthesiol"},{"issue":"2","key":"1475_CR9","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s43440-021-00232-4","volume":"73","author":"S Kohtala","year":"2021","unstructured":"Kohtala S. Ketamine\u201450 years in use: from anesthesia to rapid antidepressant effects and neurobiological mechanisms. Pharmacol Rep. 2021;73(2):323\u201345. https:\/\/doi.org\/10.1007\/s43440-021-00232-4.","journal-title":"Pharmacol Rep"},{"key":"1475_CR10","doi-asserted-by":"publisher","unstructured":"Li L, Vlisides PE. Ketamine: 50 Years of Modulating the Mind. Front Hum Neurosci. 2016;10. https:\/\/doi.org\/10.3389\/fnhum.2016.00612.","DOI":"10.3389\/fnhum.2016.00612"},{"issue":"3\u20134","key":"1475_CR11","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1080\/02791072.1980.10471430","volume":"12","author":"EF Domino","year":"1980","unstructured":"Domino EF. History and pharmacology of PCP and PCP-related analogs. J Psychedelic Drugs. 1980;12(3\u20134):223\u20137. https:\/\/doi.org\/10.1080\/02791072.1980.10471430.","journal-title":"J Psychedelic Drugs"},{"key":"1475_CR12","unstructured":"Diversion Control Division | Drug and Chemical Information - Ketamine. Accessed February 25. 2026. https:\/\/deadiversion.usdoj.gov\/drug_chem_info\/ketamine.html"},{"issue":"3","key":"1475_CR13","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1097\/ALN.0b013e3181ed09a2","volume":"113","author":"EF Domino","year":"2010","unstructured":"Domino EF, Warner DS. Taming the ketamine tiger. Anesthesiology. 2010;113(3):678\u201384. https:\/\/doi.org\/10.1097\/ALN.0b013e3181ed09a2.","journal-title":"Anesthesiology"},{"issue":"6","key":"1475_CR14","doi-asserted-by":"publisher","first-page":"e1414","DOI":"10.1097\/MJT.0000000000000257","volume":"23","author":"BM Radvansky","year":"2016","unstructured":"Radvansky BM, Puri S, Sifonios AN, Eloy JD, Le V. Ketamine\u2014A Narrative Review of Its Uses in Medicine. Am J Ther. 2016;23(6):e1414\u201326. https:\/\/doi.org\/10.1097\/MJT.0000000000000257.","journal-title":"Am J Ther"},{"key":"1475_CR15","unstructured":"DailyMed -. KETALAR- ketamine hydrochloride injection. Accessed February 25, 2026. https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=46dab560-8ecd-4d92-8c92-6baa2310b09b"},{"issue":"2","key":"1475_CR16","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1093\/bja\/57.2.197","volume":"57","author":"PF White","year":"1985","unstructured":"White PF, Sch\u00fcttler J, Shafer A, Stanski DR, Horai Y, Trevor AJ. COMPARATIVE PHARMACOLOGY OF THE KETAMINE ISOMERS. Br J Anaesth. 1985;57(2):197\u2013203. https:\/\/doi.org\/10.1093\/bja\/57.2.197.","journal-title":"Br J Anaesth"},{"issue":"2","key":"1475_CR17","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1177\/0269881120959644","volume":"35","author":"LA Jelen","year":"2021","unstructured":"Jelen LA, Young AH, Stone JM. Ketamine: A tale of two enantiomers. J Psychopharmacol. 2021;35(2):109\u201323. https:\/\/doi.org\/10.1177\/0269881120959644.","journal-title":"J Psychopharmacol"},{"key":"1475_CR18","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.euroneuro.2021.01.005","volume":"44","author":"T Passie","year":"2021","unstructured":"Passie T, Adams HA, Logemann F, Brandt SD, Wiese B, Karst M. Comparative effects of (S)-ketamine and racemic (R\/S)-ketamine on psychopathology, state of consciousness and neurocognitive performance in healthy volunteers. Eur Neuropsychopharmacol. 2021;44:92\u2013104. https:\/\/doi.org\/10.1016\/j.euroneuro.2021.01.005.","journal-title":"Eur Neuropsychopharmacol"},{"issue":"10","key":"1475_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12102283","volume":"12","author":"P Kawczak","year":"2024","unstructured":"Kawczak P, Feszak I, B\u0105czek T. Ketamine, Esketamine, and Arketamine: Their Mechanisms of Action and Applications in the Treatment of Depression and Alleviation of Depressive Symptoms. Biomedicines. 2024;12(10):2283. https:\/\/doi.org\/10.3390\/biomedicines12102283.","journal-title":"Biomedicines"},{"issue":"12","key":"1475_CR20","doi-asserted-by":"publisher","first-page":"4939","DOI":"10.1038\/s41380-022-01629-0","volume":"28","author":"I Shim","year":"2023","unstructured":"Shim I. Distinct functions of S-ketamine and R-ketamine in mediating biobehavioral processes of drug dependency: comments on Bonaventura et al. Mol Psychiatry. 2023;28(12):4939\u201340. https:\/\/doi.org\/10.1038\/s41380-022-01629-0.","journal-title":"Mol Psychiatry"},{"key":"1475_CR21","unstructured":"Micromedex drug database | Merative. Accessed February 25. 2026. https:\/\/www.merative.com\/clinical-decision-support\/micromedex"},{"key":"1475_CR22","unstructured":"Dahan A. Ketamine: Fundamentals, Applications, Pharmacology, and Clinical Aspects. 1st ed. Elsevier Science & Technology; 2025."},{"issue":"13","key":"1475_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/molecules30132824","volume":"30","author":"E Gibu\u0142a-Tar\u0142owska","year":"2025","unstructured":"Gibu\u0142a-Tar\u0142owska E, Wiszniewska A, Turyk M, Szymczyk P, Kotli\u0144ska JH, K\u0119dzierska E. Ketamine\u2014From an Anesthetic to a Psychiatric Drug: Mechanisms of Action, Clinical Applications and Potential Risks. Molecules. 2025;30(13):2824. https:\/\/doi.org\/10.3390\/molecules30132824.","journal-title":"Molecules"},{"key":"1475_CR24","doi-asserted-by":"publisher","unstructured":"Clements JA, Nimmo WS, Grant IS, Boudieu L, Mennetrier M, Llorca PM, Samalin L. Bioavailability, Pharmacokinetics, and Analgesic Activity of Ketamine in Humans. J Pharm Sci. 1982;71(5):539\u2013542. https:\/\/doi.org\/10.1002\/jps.2600710516\u00a0.","DOI":"10.1002\/jps.2600710516"},{"key":"1475_CR25","doi-asserted-by":"crossref","unstructured":"Loo CK, G\u00e1lvez V, O\u2019Keefe E,. Placebo-controlled pilot trial testing dose titration and intravenous, intramuscular and subcutaneous routes for ketamine in depression. Acta Psychiatr Scand. 2016;134(1):48\u201356. https:\/\/doi.org\/10.1111\/acps.12572.","DOI":"10.1111\/acps.12572"},{"key":"1475_CR26","unstructured":"Depressive disorder (depression). Accessed February 24. 2026. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/depression"},{"key":"1475_CR27","unstructured":"Global Burden of Disease (GBD). Accessed February 25. 2026. https:\/\/www.healthdata.org\/research-analysis\/gbd-data"},{"key":"1475_CR28","doi-asserted-by":"publisher","unstructured":"Terlizzi EP, Zablotsky B. Symptoms of Anxiety and Depression Among Adults: United States, 2019 and 2022. Natl Health Stat Rep. 2024;213:CS353885. https:\/\/doi.org\/10.15620\/cdc\/64018.","DOI":"10.15620\/cdc\/64018"},{"key":"1475_CR29","unstructured":"Bains N, Abdijadid S. Major Depressive Disorder. In: StatPearls. StatPearls Publishing; 2025. Accessed February 24, 2026. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK559078\/"},{"key":"1475_CR30","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.jad.2017.05.003","volume":"219","author":"CA Woody","year":"2017","unstructured":"Woody CA, Ferrari AJ, Siskind DJ, Whiteford HA, Harris MG. A systematic review and meta-regression of the prevalence and incidence of perinatal depression. J Affect Disord. 2017;219:86\u201392. https:\/\/doi.org\/10.1016\/j.jad.2017.05.003.","journal-title":"J Affect Disord"},{"key":"1475_CR31","unstructured":"Bamalan OA, Moore MJ, Al Khalili Y, Physiology. Serotonin. In: StatPearls. StatPearls Publishing; 2025. Accessed February 24, 2026. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK545168\/"},{"issue":"1","key":"1475_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01738-y","volume":"9","author":"L Cui","year":"2024","unstructured":"Cui L, Li S, Wang S, et al. Major depressive disorder: hypothesis, mechanism, prevention and treatment. Signal Transduct Target Ther. 2024;9(1):30. https:\/\/doi.org\/10.1038\/s41392-024-01738-y.","journal-title":"Signal Transduct Target Ther"},{"issue":"3","key":"1475_CR33","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1177\/02698811231161813","volume":"37","author":"S Jauhar","year":"2023","unstructured":"Jauhar S, Cowen PJ, Browning M. Fifty years on: Serotonin and depression. J Psychopharmacol (Oxf). 2023;37(3):237\u201341. https:\/\/doi.org\/10.1177\/02698811231161813.","journal-title":"J Psychopharmacol (Oxf)"},{"key":"1475_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2025.1572462","volume":"19","author":"Y Shu","year":"2025","unstructured":"Shu Y, Tian L, Wang X, Meng T, Yu S, Li Y. Decoding serotonin: the molecular symphony behind depression. Front Cell Neurosci. 2025;19:1572462. https:\/\/doi.org\/10.3389\/fncel.2025.1572462.","journal-title":"Front Cell Neurosci"},{"key":"1475_CR35","unstructured":"Jewett BE, Thapa B, Physiology. NMDA Receptor. In: StatPearls. StatPearls Publishing; 2025. Accessed February 24, 2026. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK519495\/"},{"key":"1475_CR36","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.bbr.2017.12.025","volume":"341","author":"E Jesulola","year":"2018","unstructured":"Jesulola E, Micalos P, Baguley IJ. Understanding the pathophysiology of depression: From monoamines to the neurogenesis hypothesis model - are we there yet? Behav Brain Res. 2018;341:79\u201390. https:\/\/doi.org\/10.1016\/j.bbr.2017.12.025.","journal-title":"Behav Brain Res"},{"issue":"8","key":"1475_CR37","doi-asserted-by":"publisher","first-page":"3243","DOI":"10.1038\/s41380-022-01661-0","volume":"28","author":"J Moncrieff","year":"2023","unstructured":"Moncrieff J, Cooper RE, Stockmann T, Amendola S, Hengartner MP, Horowitz MA. The serotonin theory of depression: a systematic umbrella review of the evidence. Mol Psychiatry. 2023;28(8):3243\u201356. https:\/\/doi.org\/10.1038\/s41380-022-01661-0.","journal-title":"Mol Psychiatry"},{"issue":"1","key":"1475_CR38","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1176\/appi.ajp.163.1.28","volume":"163","author":"MH Trivedi","year":"2006","unstructured":"Trivedi MH, Rush AJ, Wisniewski SR, et al. Evaluation of Outcomes With Citalopram for Depression Using Measurement-Based Care in STAR*D: Implications for Clinical Practice. Am J Psychiatry. 2006;163(1):28\u201340. https:\/\/doi.org\/10.1176\/appi.ajp.163.1.28.","journal-title":"Am J Psychiatry"},{"key":"1475_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2017.00305","volume":"11","author":"B Liu","year":"2017","unstructured":"Liu B, Liu J, Wang M, Zhang Y, Li L. From Serotonin to Neuroplasticity: Evolvement of Theories for Major Depressive Disorder. Front Cell Neurosci. 2017;11:305. https:\/\/doi.org\/10.3389\/fncel.2017.00305.","journal-title":"Front Cell Neurosci"},{"key":"1475_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2025.1621887","volume":"16","author":"A Uyar","year":"2025","unstructured":"Uyar A, Gonul AS. New and emerging pharmacologic treatments for MDD. Front Psychiatry. 2025;16:1621887. https:\/\/doi.org\/10.3389\/fpsyt.2025.1621887.","journal-title":"Front Psychiatry"},{"issue":"4","key":"1475_CR41","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/S0006-3223(99)00230-9","volume":"47","author":"RM Berman","year":"2000","unstructured":"Berman RM, Cappiello A, Anand A, et al. Antidepressant effects of ketamine in depressed patients. Biol Psychiatry. 2000;47(4):351\u20134. https:\/\/doi.org\/10.1016\/S0006-3223(99)00230-9.","journal-title":"Biol Psychiatry"},{"issue":"8","key":"1475_CR42","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.63.8.856","volume":"63","author":"CA Zarate","year":"2006","unstructured":"Zarate CA, Singh JB, Carlson PJ, et al. A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry. 2006;63(8):856. https:\/\/doi.org\/10.1001\/archpsyc.63.8.856.","journal-title":"Arch Gen Psychiatry"},{"issue":"4","key":"1475_CR43","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.biopsych.2012.10.019","volume":"74","author":"CA Zarate","year":"2013","unstructured":"Zarate CA, Mathews D, Ibrahim L, et al. A randomized trial of a low-trapping nonselective N-methyl-D-aspartate channel blocker in major depression. Biol Psychiatry. 2013;74(4):257\u201364. https:\/\/doi.org\/10.1016\/j.biopsych.2012.10.019.","journal-title":"Biol Psychiatry"},{"issue":"5","key":"1475_CR44","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1176\/appi.ajp.2018.18070834","volume":"176","author":"JL Phillips","year":"2019","unstructured":"Phillips JL, Norris S, Talbot J, et al. Single, repeated, and maintenance ketamine infusions for treatment-resistant depression: a randomized controlled trial. Am J Psychiatry. 2019;176(5):401\u20139. https:\/\/doi.org\/10.1176\/appi.ajp.2018.18070834.","journal-title":"Am J Psychiatry"},{"issue":"3","key":"1475_CR45","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1001\/archpsyc.1994.03950030035004","volume":"51","author":"JH Krystal","year":"1994","unstructured":"Krystal JH. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans: psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry. 1994;51(3):199. https:\/\/doi.org\/10.1001\/archpsyc.1994.03950030035004.","journal-title":"Arch Gen Psychiatry"},{"key":"1475_CR46","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.jad.2019.11.028","volume":"263","author":"EE Acevedo-Diaz","year":"2020","unstructured":"Acevedo-Diaz EE, Cavanaugh GW, Greenstein D, et al. Comprehensive assessment of side effects associated with a single dose of ketamine in treatment-resistant depression. J Affect Disord. 2020;263:568\u201375. https:\/\/doi.org\/10.1016\/j.jad.2019.11.028.","journal-title":"J Affect Disord"},{"issue":"1","key":"1475_CR47","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s44192-022-00012-3","volume":"2","author":"M Yavi","year":"2022","unstructured":"Yavi M, Lee H, Henter ID, Park LT, Zarate CA. Ketamine treatment for depression: a review. Discov Ment Health. 2022;2(1):9. https:\/\/doi.org\/10.1007\/s44192-022-00012-3.","journal-title":"Discov Ment Health"},{"key":"1475_CR48","unstructured":"Last Review Status\/Date: Accessed February 25. 2026. https:\/\/www.fepblue.org\/-\/media\/PDFs\/Medical-Policies\/2025\/January\/Pharmacy-Policies\/Remove-and-Replace\/560033-Spravato-esketamine-nasal-spray.pdf"},{"key":"1475_CR49","unstructured":"Guidance on the Safe Use of Ketamine Outside of Acute Pain Management and Procedural Sedation. Accessed February 24. 2026. https:\/\/www.asahq.org\/advocating-for-you\/guidance\/ketamine-safe-use"},{"issue":"1","key":"1475_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-024-02973-1","volume":"14","author":"Z Shen","year":"2024","unstructured":"Shen Z, Gao D, Lv X, Wang H, Yue W. A meta-analysis of the effects of ketamine on suicidal ideation in depression patients. Transl Psychiatry. 2024;14(1):248. https:\/\/doi.org\/10.1038\/s41398-024-02973-1.","journal-title":"Transl Psychiatry"},{"key":"1475_CR51","doi-asserted-by":"publisher","unstructured":"Dean RL, Hurducas C, Hawton K, et al. Ketamine and other glutamate receptor modulators for depression in adults with unipolar major depressive disorder. Cochrane Database Syst Rev. 2021. https:\/\/doi.org\/10.1002\/14651858.CD011612.pub3.","DOI":"10.1002\/14651858.CD011612.pub3"},{"issue":"4","key":"1475_CR52","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2017.0080","volume":"74","author":"G Sanacora","year":"2017","unstructured":"Sanacora G, Frye MA, McDonald W, et al. A consensus statement on the use of ketamine in the treatment of mood disorders. JAMA Psychiatry. 2017;74(4):399. https:\/\/doi.org\/10.1001\/jamapsychiatry.2017.0080.","journal-title":"JAMA Psychiatry"},{"key":"1475_CR53","unstructured":"Page 50 HS 16 min read V 55\u00a0N 4 P version. The emergence of psychedelics as medicine. https:\/\/www.apa.org. Accessed February 25, 2026. https:\/\/www.apa.org."},{"issue":"2","key":"1475_CR54","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1111\/bcp.12094","volume":"77","author":"M Niesters","year":"2014","unstructured":"Niesters M, Martini C, Dahan A. Ketamine for chronic pain: risks and benefits. Br J Clin Pharmacol. 2014;77(2):357\u201367. https:\/\/doi.org\/10.1111\/bcp.12094.","journal-title":"Br J Clin Pharmacol"},{"issue":"2\u20133","key":"1475_CR55","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.tacc.2014.03.002","volume":"4","author":"J Sleigh","year":"2014","unstructured":"Sleigh J, Harvey M, Voss L, Denny B. Ketamine \u2013 more mechanisms of action than just NMDA blockade. Trends Anaesth Crit Care. 2014;4(2\u20133):76\u201381. https:\/\/doi.org\/10.1016\/j.tacc.2014.03.002.","journal-title":"Trends Anaesth Crit Care"},{"issue":"9","key":"1475_CR56","doi-asserted-by":"publisher","first-page":"2320","DOI":"10.1097\/j.pain.0000000000002231","volume":"162","author":"MV Velzen","year":"2021","unstructured":"Velzen MV, Dahan JDC, Van Dorp ELA, Mogil JS, Hooijmans CR, Dahan A. Efficacy of ketamine in relieving neuropathic pain: a systematic review and meta-analysis of animal studies. Pain. 2021;162(9):2320\u201330. https:\/\/doi.org\/10.1097\/j.pain.0000000000002231.","journal-title":"Pain"},{"key":"1475_CR57","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.2147\/JPR.S358070","volume":"15","author":"JE Guimar\u00e3es Pereira","year":"2022","unstructured":"Guimar\u00e3es Pereira JE, Ferreira Gomes Pereira L, Mercante Linhares R, Darcy Alves Bersot C, Aslanidis T, Ashmawi HA. Efficacy and safety of ketamine in the treatment of neuropathic pain: a systematic review and meta-analysis of randomized controlled trials. J Pain Res. 2022;15:1011\u201337. https:\/\/doi.org\/10.2147\/JPR.S358070.","journal-title":"J Pain Res"},{"key":"1475_CR58","doi-asserted-by":"publisher","unstructured":"Gordeen A, Zemmedhun G, Abd-Elsayed A, Yolland M. Ketamine infusion and its role in chronic pain. ASRA News. 2022;46(3). https:\/\/doi.org\/10.52211\/asra080122.036.","DOI":"10.52211\/asra080122.036"},{"issue":"7","key":"1475_CR59","doi-asserted-by":"publisher","first-page":"446","DOI":"10.4103\/0019-5049.160963","volume":"59","author":"S Mitra","year":"2015","unstructured":"Mitra S, Kazal S. Oral ketamine for phantom limb pain: an option for challenging cases. Indian J Anaesth. 2015;59(7):446. https:\/\/doi.org\/10.4103\/0019-5049.160963.","journal-title":"Indian J Anaesth"},{"issue":"9","key":"1475_CR60","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12093256","volume":"12","author":"A Riccardi","year":"2023","unstructured":"Riccardi A, Guarino M, Serra S, et al. Narrative review: low-dose ketamine for pain management. J Clin Med. 2023;12(9):3256. https:\/\/doi.org\/10.3390\/jcm12093256.","journal-title":"J Clin Med"},{"issue":"24","key":"1475_CR61","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13247699","volume":"13","author":"D Viderman","year":"2024","unstructured":"Viderman D, Mukazhan D, Kapessova K, Tungushpayev M, Badenes R. The impact of ketamine on outcomes in acute pain management: an umbrella review. J Clin Med. 2024;13(24):7699. https:\/\/doi.org\/10.3390\/jcm13247699.","journal-title":"J Clin Med"}],"container-title":["Current Pain and Headache Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11916-026-01475-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11916-026-01475-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11916-026-01475-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T06:34:28Z","timestamp":1776753268000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11916-026-01475-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,21]]},"references-count":61,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["1475"],"URL":"https:\/\/doi.org\/10.1007\/s11916-026-01475-7","relation":{},"ISSN":["1531-3433","1534-3081"],"issn-type":[{"value":"1531-3433","type":"print"},{"value":"1534-3081","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,21]]},"assertion":[{"value":"7 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article is based on previous studies and contains no new studies with human participants or animals performed by any authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Guidelines"}},{"value":"ADK is the editor-in-chief of CPHRs.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"48"}}